Skip To Main Content

Belvarafenib (pan-RAF inhibitor)

(RG6185)

Solid Tumor

Phase I

HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

NCT03284502